Memórias do Instituto Oswaldo Cruz
Fundação Oswaldo Cruz, Fiocruz
Vol. 100, No. s1, 2005, pp. 83-91
Bioline Code: oc05031
Full paper language: English
Document type: Research Article
Document available free of charge
Memórias do Instituto Oswaldo Cruz, Vol. 100, No. s1, 2005, pp. 83-91
© Copyright 2005 - Instituto Oswaldo Cruz - Fiocruz.
Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase|
Hugo C Castro Faria Neto; Diana M Stafforini; Stephen M Prescott & Guy A Zimmerman
Platelet-activating factor (PAF) is one of the most potent lipid mediators involved in inflammatory events. The acetyl group at the sn-2 position of its glycerol backbone is essential for its biological activity. Deacetylation induces the formation of the inactive metabolite lyso-PAF. This deacetylation reaction is catalyzed by PAF-acetylhydrolase (PAF-AH), a calcium independent phospholipase A2 that also degrades a family of PAF-like oxidized phospholipids with short sn-2 residues. Biochemical and enzymological evaluations revealed that at least three types of PAF-AH exist in mammals, namely the intracellular types I and II and a plasma type. Many observations indicate that plasma PAF AH terminates signals by PAF and oxidized PAFlike lipids and thereby regulates inflammatory responses. In this review, we will focus on the potential of PAF-AH as a modulator of diseases of dysregulated inflammation.
platelet-activating factor - platelet-activating factor -acethylhydrolase - inflammatory disease - sepsis
Alternative site location: http://memorias.ioc.fiocruz.br